These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 27593227)

  • 1. Beta-Blockers and Fetal Growth Restriction in Pregnant Women With Cardiovascular Disease.
    Tanaka K; Tanaka H; Kamiya C; Katsuragi S; Sawada M; Tsuritani M; Yoshida M; Iwanaga N; Yoshimatsu J; Ikeda T
    Circ J; 2016 Sep; 80(10):2221-6. PubMed ID: 27593227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with oral beta-blockers during pregnancy complicated by maternal heart disease increases the risk of fetal growth restriction.
    Ersbøll AS; Hedegaard M; Søndergaard L; Ersbøll M; Johansen M
    BJOG; 2014 Apr; 121(5):618-26. PubMed ID: 24400736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. α/β- and β-Blocker Exposure in Pregnancy and the Risk of Neonatal Hypoglycemia and Small for Gestational Age.
    Kubota K; Inai K; Shimada E; Shinohara T
    Circ J; 2023 Mar; 87(4):569-577. PubMed ID: 36823100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-blocker subtypes and risk of low birth weight in newborns.
    Duan L; Ng A; Chen W; Spencer HT; Lee MS
    J Clin Hypertens (Greenwich); 2018 Nov; 20(11):1603-1609. PubMed ID: 30267456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy outcome and placental findings in pregnancies complicated by fetal growth restriction with and without preeclampsia.
    Kovo M; Schreiber L; Elyashiv O; Ben-Haroush A; Abraham G; Bar J
    Reprod Sci; 2015 Mar; 22(3):316-21. PubMed ID: 25001023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late Pregnancy β Blocker Exposure and Risks of Neonatal Hypoglycemia and Bradycardia.
    Bateman BT; Patorno E; Desai RJ; Seely EW; Mogun H; Maeda A; Fischer MA; Hernandez-Diaz S; Huybrechts KF
    Pediatrics; 2016 Sep; 138(3):. PubMed ID: 27577580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrauterine Growth Retardation in Pregnant Women with Long QT Syndrome Treated with Beta-Receptor Blockers.
    Welzel T; Donner B; van den Anker JN
    Neonatology; 2021; 118(4):406-415. PubMed ID: 34186538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The "weight" of fetal growth restriction in 437 hypertensive pregnancies.
    Tranquilli AL; Giannubilo SR
    Arch Gynecol Obstet; 2004 Dec; 270(4):214-6. PubMed ID: 12942263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perinatal outcomes after in-utero exposure to beta-blockers in women with heart disease: Data from the ESC EORP registry of pregnancy and cardiac disease (ROPAC).
    Ramlakhan KP; Roos-Hesselink JW; Basso T; Greenslade J; Flint RB; Krieger EV; Shotan A; Budts W; De Backer J; Hall R; Johnson MR; Parsonage WA;
    Int J Cardiol; 2024 Sep; 410():132234. PubMed ID: 38844094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
    J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features of fetal growth restriction complicated later by preeclampsia.
    Mitani M; Matsuda Y; Makino Y; Akizawa Y; Ohta H
    J Obstet Gynaecol Res; 2009 Oct; 35(5):882-7. PubMed ID: 20149036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current concepts: beta-blockers in pregnancy.
    Rubin PC
    N Engl J Med; 1981 Nov; 305(22):1323-6. PubMed ID: 6117014
    [No Abstract]   [Full Text] [Related]  

  • 13. A case control study of gene environmental interaction in fetal growth restriction with special reference to organochlorine pesticides.
    Sharma E; Mustafa M; Pathak R; Guleria K; Ahmed RS; Vaid NB; Banerjee BD
    Eur J Obstet Gynecol Reprod Biol; 2012 Apr; 161(2):163-9. PubMed ID: 22310945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-adrenergic blocking agents in the treatment of pregnancy-induced hypertension.
    Paran E; Holzberg G; Mazor M; Zmora E; Insler V
    Int J Clin Pharmacol Ther; 1995 Feb; 33(2):119-23. PubMed ID: 7757311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of placental neuropilin-1 in fetal growth restriction.
    Maulik D; De A; Ragolia L; Evans J; Grigoryev D; Lankachandra K; Mundy D; Muscat J; Gerkovich MM; Ye SQ
    Am J Obstet Gynecol; 2016 Feb; 214(2):279.e1-279.e9. PubMed ID: 26409917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Are the theoretical drawbacks of beta-blocker treatment in pregnancy being confirmed? A review of the literature].
    Tcherdakoff P; Goupil-Colliard M
    J Pharmacol; 1983; 14 Suppl 2():143-50. PubMed ID: 6138464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnancy outcome after gestational exposure to amiodarone in Canada.
    Magee LA; Downar E; Sermer M; Boulton BC; Allen LC; Koren G
    Am J Obstet Gynecol; 1995 Apr; 172(4 Pt 1):1307-11. PubMed ID: 7726275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caution in use of beta blockers during pregnancy.
    Cheng TO
    Cathet Cardiovasc Diagn; 1995 Feb; 34(2):186. PubMed ID: 7788700
    [No Abstract]   [Full Text] [Related]  

  • 19. Adrenergic beta-receptor blockers in hypertension of pregnancy.
    Sandström B
    Clin Exp Hypertens B; 1982; 1(1):127-41. PubMed ID: 6135521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The placental component in early-onset and late-onset preeclampsia in relation to fetal growth restriction.
    Kovo M; Schreiber L; Ben-Haroush A; Gold E; Golan A; Bar J
    Prenat Diagn; 2012 Jul; 32(7):632-7. PubMed ID: 22565848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.